Last reviewed · How we verify

Prilocaine HCl % 2 injectable solution — Competitive Intelligence Brief

Prilocaine HCl % 2 injectable solution (Prilocaine HCl % 2 injectable solution) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Local anesthetic (amide class). Area: Anesthesia.

marketed Local anesthetic (amide class) Voltage-gated sodium channels Anesthesia Small molecule Live · refreshed every 30 min

Target snapshot

Prilocaine HCl % 2 injectable solution (Prilocaine HCl % 2 injectable solution) — Bozyaka Training and Research Hospital. Prilocaine HCl is a local anesthetic that blocks sodium channels in nerve cell membranes, preventing the initiation and conduction of nerve impulses.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Prilocaine HCl % 2 injectable solution TARGET Prilocaine HCl % 2 injectable solution Bozyaka Training and Research Hospital marketed Local anesthetic (amide class) Voltage-gated sodium channels
Bupivacaine 0.5 % with Epinephrine Bupivacaine 0.5 % with Epinephrine Holy Cross Hospital, Florida marketed Local anesthetic with vasopressor Voltage-gated sodium channels
lidocaine + epinephrine 1:100,000 lidocaine + epinephrine 1:100,000 Weill Medical College of Cornell University marketed Local anesthetic with vasoconstrictor Voltage-gated sodium channels (lidocaine); alpha-1 and beta-1 adrenergic receptors (epinephrine)
Ropivacaine + saline solution Ropivacaine + saline solution Federal University of Minas Gerais marketed Local anesthetic (amide class) Voltage-gated sodium channels
Bupivacaine Spinal 0,5% Heavy - titration Bupivacaine Spinal 0,5% Heavy - titration Centre of Postgraduate Medical Education marketed Local anesthetic (amide class) Voltage-gated sodium channels (Nav)
LMX 4 Topical Cream LMX 4 Topical Cream Rush University Medical Center marketed Local anesthetic Voltage-gated sodium channels
blind injection of Mepivacaine blind injection of Mepivacaine Complejo Hospitalario Universitario de Granada marketed Local anesthetic (amide class) Voltage-gated sodium channels

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Local anesthetic (amide class) class)

  1. Ain Shams University · 2 drugs in this class
  2. Başakşehir Çam & Sakura City Hospital · 2 drugs in this class
  3. TriHealth Inc. · 2 drugs in this class
  4. Centre of Postgraduate Medical Education · 2 drugs in this class
  5. Bozyaka Training and Research Hospital · 2 drugs in this class
  6. Complejo Hospitalario Universitario de Granada · 1 drug in this class
  7. Clinique Saint-Jean, Bruxelles · 1 drug in this class
  8. Hospital Clínico Universitario de Valencia · 1 drug in this class
  9. Fundacion Clinica Valle del Lili · 1 drug in this class
  10. Federal University of Minas Gerais · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Prilocaine HCl % 2 injectable solution — Competitive Intelligence Brief. https://druglandscape.com/ci/prilocaine-hcl-2-injectable-solution. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing